Still in time for the March Molecule of the month @buildmodels! The crystal structure of the extracellular part of the VEGF receptor. It exists in its monomeric state when inactive, but dimerizes when it binds to VegF
https://t.co/9TqCj8HyDC
Don’t miss this latest article in Nature, discussing our collaboration with the Hubrecht Institute and other organizations in the race to scale-up #COVID19 diagnosis.
Read the article in full here! https://t.co/oG1QAFdwA8
#Diagnostics#LabAutomation
Researchers from the Hubrecht Institute, @Genmab and many other parties have published the developmental journey and protocols of the STRIP-1 test robot in @NatureBiotech today! Read more: https://t.co/zfBTAmexyx
Dissecting multi-site phosphorylation of 4E-BP1 by mTORC1 using #NMR in collab with @HillerLab @Biozentrum_en. First structural analysis of hierarchical substrate phosphorylation by mTOR reveals mechanistic basis for efficient control of translation. https://t.co/fx0JxyShYH
The Hubrecht Institute, @Genmab, and many others have developed a new robot, the STRIP-1 - testrobot, that can process up to 20,000 samples for #COVID-19 testing per 24 hours, making it much faster than all other systems to date. Read more: https://t.co/4ZZLIkRtve
Genmab’s Martijn Bosch explains how the STRIP-1, a new testing robot that Genmab developed with @_Hubrecht and other partners is helping increase testing capacity in the Netherlands.
In the first weeks of the #COVID19 pandemic, Genmab researchers and experts joined @_Hubrecht and molecular biologists in the Netherlands to develop a high-tech molecular test robot nicknamed “The Beast” to help the Netherlands prepare for future pandemic needs.
We are happy to finally share the final version of our story on the structure of human mTORC2. Herein, insights into the molecular basis of growth factor signaling and its regulation.
https://t.co/eWu3nL809P
Extremely happy and proud to share our recent work on mTORC2, now out on Science Advances! A great story and a great collaboration between @MaierLab@The_Ban_Lab@HallLab@UniBasel@ETH https://t.co/2lANlHz73W
📢Our rapid response to the COVID-19 pandemic on @biorxivpreprint
„Synthetic nanobodies targeting the SARS-CoV-2 receptor-binding domain“
The sequences of the 63 unique anti-RBD #sybodies selected within 12 working days are open access.
https://t.co/wZVXP2sK7d
If you missed it, our latest collaboration with @MaierLab and Mike Hall’s lab is available on BioRxiv https://t.co/OjYY48J7lY . Great work by @skaiiol and @FranciMangia reveals Rictor's architecture and visualizes two small molecule binding sites, one of them found in Rictor!